Phibro Animal Health (NASDAQ:PAHC) Lifted to “Sell” at BidaskClub

BidaskClub upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a strong sell rating to a sell rating in a report released on Thursday, December 21st.

Other analysts have also recently issued reports about the company. Zacks Investment Research upgraded Phibro Animal Health from a hold rating to a buy rating and set a $41.00 target price on the stock in a report on Tuesday, October 31st. Piper Jaffray Companies set a $41.00 price target on Phibro Animal Health and gave the stock a buy rating in a report on Friday, October 6th. ValuEngine cut Phibro Animal Health from a buy rating to a hold rating in a report on Thursday, November 9th. Credit Suisse Group increased their price target on Phibro Animal Health from $36.00 to $37.00 and gave the stock an outperform rating in a report on Thursday, August 31st. Finally, Bank of America restated an underperform rating and set a $33.00 price target on shares of Phibro Animal Health in a report on Wednesday, August 23rd. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus price target of $38.25.

Phibro Animal Health (NASDAQ PAHC) opened at $35.70 on Thursday. Phibro Animal Health has a 52 week low of $26.10 and a 52 week high of $40.25. The stock has a market capitalization of $1,434.53, a P/E ratio of 21.00, a PEG ratio of 4.17 and a beta of 1.27. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Monday, November 6th. The company reported $0.38 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.01. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The business had revenue of $193.40 million for the quarter, compared to analysts’ expectations of $189.89 million. During the same period in the prior year, the business posted $0.36 earnings per share. The firm’s revenue was up 2.9% on a year-over-year basis. analysts expect that Phibro Animal Health will post 1.57 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 27th. Investors of record on Wednesday, December 6th were issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date was Tuesday, December 5th. Phibro Animal Health’s dividend payout ratio is currently 23.53%.

Several institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of Phibro Animal Health by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 1,780,880 shares of the company’s stock worth $65,982,000 after purchasing an additional 51,474 shares in the last quarter. Copper Rock Capital Partners LLC raised its position in Phibro Animal Health by 9.6% in the 4th quarter. Copper Rock Capital Partners LLC now owns 631,876 shares of the company’s stock valued at $21,326,000 after buying an additional 55,235 shares during the last quarter. FMR LLC raised its position in Phibro Animal Health by 31.9% in the 2nd quarter. FMR LLC now owns 584,463 shares of the company’s stock valued at $21,654,000 after buying an additional 141,274 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Phibro Animal Health by 11.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 465,297 shares of the company’s stock valued at $17,239,000 after buying an additional 49,296 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its position in Phibro Animal Health by 26.7% in the 3rd quarter. Ameriprise Financial Inc. now owns 430,656 shares of the company’s stock valued at $15,958,000 after buying an additional 90,660 shares during the last quarter. Institutional investors own 48.42% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Phibro Animal Health (NASDAQ:PAHC) Lifted to “Sell” at BidaskClub” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/14/phibro-animal-health-pahc-upgraded-to-sell-at-bidaskclub.html.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply